Crossmark

HATRIC: a study of Pelargonium sidoides root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults—study protocol for a double blind, placebo-controlled randomised feasibility trial

Crossref DOI link: https://doi.org/10.1186/s40814-019-0478-6

Published Online: 2019-07-31

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Whitehead, Amy https://orcid.org/0000-0002-2840-6876
Simpson, Catherine

Willcox, Merlin

Webley, Frances

Hay, Alastair D.

Butler, Chris

Yao, Lily

Wrixon, Emma

Bell, Margaret

Bostock, Jennifer

Little, Paul

Griffiths, Gareth

Moore, Michael
Funding

Funding for this research was provided by:

NIHR School for Primary Care Research (336)
License Information

Text and Data Mining valid from 2019-07-31

Version of Record valid from 2019-07-31
More Information

Article History

Received: 23 January 2019

Accepted: 9 July 2019

First Online: 31 July 2019

Ethics approval and consent to participate

: The trial received favourable ethical opinion from the South Central–Berkshire B Research Ethics Committee (17/SC/0653). All patients provide written informed consent to participate and are free to withdraw at any time.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below